Honestly think the only way this moves to new levels is remove Camille, and change the name. Luckily there's 4 or 5 bios attached to this, or owned by a director. NOX pharma already holds the rights to adva27a, according to their filings. NOX pharma is a Shell owned by sbfm attorney, but shares sbfm address.....?